The brain imaging modalities market size has grown strongly in recent years. It will grow from $13.9 billion in 2025 to $14.76 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to limited availability of advanced brain imaging devices, high cost of early imaging equipment, growing awareness of neurological disorders, reliance on stationary imaging systems, increasing number of diagnostic centers.
The brain imaging modalities market size is expected to see strong growth in the next few years. It will grow to $18.55 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to technological advancements in fMRI and PET systems, rising adoption of portable and research-oriented imaging devices, growing investment in neuroimaging research, increasing integration of ai and big data analytics, expansion of hospitals and diagnostic facilities. Major trends in the forecast period include rising adoption of advanced mri and ct imaging techniques, increasing use of portable and point-of-care brain imaging systems, growing demand for pediatric and infant brain imaging solutions, integration of image processing software and patient monitoring systems, expansion of functional brain imaging for research and clinical applications.
The increasing prevalence of neurological disorders is anticipated to support the expansion of the brain imaging modality market going forward. Neurological disorders refer to medical conditions that affect the nervous system, including the brain, spinal cord, and nerves, leading to impairments in movement, sensation, cognition, or behavior. The rising number of neurological disorders can be attributed to factors such as population aging, improved diagnostic capabilities, chronic diseases, genetic influences, environmental changes, and lifestyle-related risks. Brain imaging modalities assist in diagnosing and monitoring neurological disorders by providing detailed visualizations of brain structure and function, enabling more effective treatment planning. For example, in January 2025, according to the European Brain Council, a Belgium-based non-profit organization, nearly 7 million people in Europe were living with Alzheimer’s disease, with estimates suggesting this figure could double to 14 million by 2030. Consequently, the growing prevalence of neurological disorders is supporting the advancement of the brain imaging modality market.
Leading companies operating in the brain imaging modalities market are concentrating on developing innovative technologies, such as advanced neuroimaging solutions, to strengthen their competitive positioning. Neuroimaging technologies are sophisticated medical tools used to capture detailed images of the brain’s structure and functional activity. For example, in February 2024, Koninklijke Philips N.V., a Netherlands-based technology company, partnered with SyntheticMR, a Sweden-based software company, to launch Smart Quant Neuro 3D. This solution delivers automated 3D quantification of neuroimaging data, real-time visualization of brain structures, and artificial intelligence integration to improve diagnostic accuracy. The innovation is designed to streamline clinical workflows, reduce image analysis time, and enhance diagnostic confidence for healthcare providers while improving patient care.
In April 2023, GE HealthCare Technologies Inc., a US-based medical technology company, acquired IMACTIS for an undisclosed amount. This acquisition is intended to enhance GE HealthCare’s technological capabilities by integrating IMACTIS’s innovative navigation solutions into its healthcare offerings. IMACTIS is a US-based company specializing in computer-assisted interventional radiology.
Major companies operating in the brain imaging modalities market are Hitachi Ltd, Siemens AG, Toshiba Corporation, FUJIFILM Corporation, Koninklijke Philips N.V, GE HealthCare Technologies Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Shimadzu Corporation, Canon Medical Systems Corporation, Neusoft Corporation, Agfa-Gevaert N.V., Carestream Health, Brainlab AG, Esaote SpA, NeuroLogica Corp., Swissray International Inc., Xoran Technologies LLC., Allengers Medical Systems Ltd., Konica Minolta Healthcare Americas Inc., Hi-Tech Medical Imaging.
North America was the largest region in the brain imaging modalities market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain imaging modalities market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the brain imaging modalities market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the brain imaging modalities market by increasing the cost of imported imaging devices such as MRI, PET, and CT scanners, as well as associated accessories like contrast agents and EEG electrodes. High-cost segments and regions including North America, Europe, and Asia-Pacific face the most significant impact due to import duties. This has led to increased operational costs for hospitals and research institutes. On the positive side, tariffs have encouraged local manufacturing, innovation in imaging device production, and investment in domestic supply chains.
The brain imaging modalities market research report is one of a series of new reports that provides brain imaging modalities market statistics, including brain imaging modalities industry global market size, regional shares, competitors with a brain imaging modalities market share, detailed brain imaging modalities market segments, market trends and opportunities, and any further data you may need to thrive in the brain imaging modalities industry. This brain imaging modalities market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Brain imaging modalities are techniques used to visualize the structure, function, and activity of the brain, helping doctors and researchers diagnose and better understand brain-related conditions. These methods assist in detecting brain disorders, studying brain function, and supporting treatment planning.
The key product types of brain imaging modalities include devices, accessories, and usability solutions. Brain imaging devices are advanced systems developed to obtain detailed structural images or functional information about the brain. The imaging techniques include computed tomography (CT), positron emission tomography (PET), magnetic resonance imaging (MRI), and single photon emission computed tomography (SPECT), while the modalities consist of stand-alone functional brain imaging systems and portable functional brain imaging systems. The patient groups include adults, pediatric patients, and infants, and these solutions are used by end users such as hospitals, diagnostic centers, and research institutions.
The brain imaging modalities market consists of sales of structural magnetic resonance imaging (MRI), high-resolution computed tomography (CT), and functional near-infrared spectroscopy (fNIRS). Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The brain imaging modalities market size is expected to see strong growth in the next few years. It will grow to $18.55 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to technological advancements in fMRI and PET systems, rising adoption of portable and research-oriented imaging devices, growing investment in neuroimaging research, increasing integration of ai and big data analytics, expansion of hospitals and diagnostic facilities. Major trends in the forecast period include rising adoption of advanced mri and ct imaging techniques, increasing use of portable and point-of-care brain imaging systems, growing demand for pediatric and infant brain imaging solutions, integration of image processing software and patient monitoring systems, expansion of functional brain imaging for research and clinical applications.
The increasing prevalence of neurological disorders is anticipated to support the expansion of the brain imaging modality market going forward. Neurological disorders refer to medical conditions that affect the nervous system, including the brain, spinal cord, and nerves, leading to impairments in movement, sensation, cognition, or behavior. The rising number of neurological disorders can be attributed to factors such as population aging, improved diagnostic capabilities, chronic diseases, genetic influences, environmental changes, and lifestyle-related risks. Brain imaging modalities assist in diagnosing and monitoring neurological disorders by providing detailed visualizations of brain structure and function, enabling more effective treatment planning. For example, in January 2025, according to the European Brain Council, a Belgium-based non-profit organization, nearly 7 million people in Europe were living with Alzheimer’s disease, with estimates suggesting this figure could double to 14 million by 2030. Consequently, the growing prevalence of neurological disorders is supporting the advancement of the brain imaging modality market.
Leading companies operating in the brain imaging modalities market are concentrating on developing innovative technologies, such as advanced neuroimaging solutions, to strengthen their competitive positioning. Neuroimaging technologies are sophisticated medical tools used to capture detailed images of the brain’s structure and functional activity. For example, in February 2024, Koninklijke Philips N.V., a Netherlands-based technology company, partnered with SyntheticMR, a Sweden-based software company, to launch Smart Quant Neuro 3D. This solution delivers automated 3D quantification of neuroimaging data, real-time visualization of brain structures, and artificial intelligence integration to improve diagnostic accuracy. The innovation is designed to streamline clinical workflows, reduce image analysis time, and enhance diagnostic confidence for healthcare providers while improving patient care.
In April 2023, GE HealthCare Technologies Inc., a US-based medical technology company, acquired IMACTIS for an undisclosed amount. This acquisition is intended to enhance GE HealthCare’s technological capabilities by integrating IMACTIS’s innovative navigation solutions into its healthcare offerings. IMACTIS is a US-based company specializing in computer-assisted interventional radiology.
Major companies operating in the brain imaging modalities market are Hitachi Ltd, Siemens AG, Toshiba Corporation, FUJIFILM Corporation, Koninklijke Philips N.V, GE HealthCare Technologies Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Shimadzu Corporation, Canon Medical Systems Corporation, Neusoft Corporation, Agfa-Gevaert N.V., Carestream Health, Brainlab AG, Esaote SpA, NeuroLogica Corp., Swissray International Inc., Xoran Technologies LLC., Allengers Medical Systems Ltd., Konica Minolta Healthcare Americas Inc., Hi-Tech Medical Imaging.
North America was the largest region in the brain imaging modalities market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain imaging modalities market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the brain imaging modalities market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the brain imaging modalities market by increasing the cost of imported imaging devices such as MRI, PET, and CT scanners, as well as associated accessories like contrast agents and EEG electrodes. High-cost segments and regions including North America, Europe, and Asia-Pacific face the most significant impact due to import duties. This has led to increased operational costs for hospitals and research institutes. On the positive side, tariffs have encouraged local manufacturing, innovation in imaging device production, and investment in domestic supply chains.
The brain imaging modalities market research report is one of a series of new reports that provides brain imaging modalities market statistics, including brain imaging modalities industry global market size, regional shares, competitors with a brain imaging modalities market share, detailed brain imaging modalities market segments, market trends and opportunities, and any further data you may need to thrive in the brain imaging modalities industry. This brain imaging modalities market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Brain imaging modalities are techniques used to visualize the structure, function, and activity of the brain, helping doctors and researchers diagnose and better understand brain-related conditions. These methods assist in detecting brain disorders, studying brain function, and supporting treatment planning.
The key product types of brain imaging modalities include devices, accessories, and usability solutions. Brain imaging devices are advanced systems developed to obtain detailed structural images or functional information about the brain. The imaging techniques include computed tomography (CT), positron emission tomography (PET), magnetic resonance imaging (MRI), and single photon emission computed tomography (SPECT), while the modalities consist of stand-alone functional brain imaging systems and portable functional brain imaging systems. The patient groups include adults, pediatric patients, and infants, and these solutions are used by end users such as hospitals, diagnostic centers, and research institutions.
The brain imaging modalities market consists of sales of structural magnetic resonance imaging (MRI), high-resolution computed tomography (CT), and functional near-infrared spectroscopy (fNIRS). Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Brain Imaging Modalities Market Characteristics
3. Brain Imaging Modalities Market Supply Chain Analysis
4. Global Brain Imaging Modalities Market Trends and Strategies
5. Brain Imaging Modalities Market Analysis of End Use Industries
7. Global Brain Imaging Modalities Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Brain Imaging Modalities Total Addressable Market (TAM) Analysis for the Market
9. Brain Imaging Modalities Market Segmentation
10. Brain Imaging Modalities Market Regional and Country Analysis
11. Asia-Pacific Brain Imaging Modalities Market
12. China Brain Imaging Modalities Market
13. India Brain Imaging Modalities Market
14. Japan Brain Imaging Modalities Market
15. Australia Brain Imaging Modalities Market
16. Indonesia Brain Imaging Modalities Market
17. South Korea Brain Imaging Modalities Market
18. Taiwan Brain Imaging Modalities Market
19. South East Asia Brain Imaging Modalities Market
20. Western Europe Brain Imaging Modalities Market
21. UK Brain Imaging Modalities Market
22. Germany Brain Imaging Modalities Market
23. France Brain Imaging Modalities Market
24. Italy Brain Imaging Modalities Market
25. Spain Brain Imaging Modalities Market
26. Eastern Europe Brain Imaging Modalities Market
27. Russia Brain Imaging Modalities Market
28. North America Brain Imaging Modalities Market
29. USA Brain Imaging Modalities Market
30. Canada Brain Imaging Modalities Market
31. South America Brain Imaging Modalities Market
32. Brazil Brain Imaging Modalities Market
33. Middle East Brain Imaging Modalities Market
34. Africa Brain Imaging Modalities Market
36. Brain Imaging Modalities Market Competitive Landscape and Company Profiles
37. Brain Imaging Modalities Market Other Major and Innovative Companies
40. Brain Imaging Modalities Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Brain Imaging Modalities Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses brain imaging modalities market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for brain imaging modalities? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The brain imaging modalities market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Devices; Accessories; Usability2) By Imaging Type: Computed Tomography (CT); Positron Emission Tomography (PET); Magnetic Resonance Imaging (MRI); Single Photon Emission Computed Tomography (SPECT)
3) By Modalities: Stand-Alone Functional Brain Imaging Systems; Portable Functional Brain Imaging Systems
4) By Patient Type: Adults; Pediatrics; Infants
5) By End-User: Hospitals; Diagnostic Centers; Research Institutes
Subsegments:
1) By Devices: Magnetic Resonance Imaging (MRI) Machines; Computed Tomography (CT) Scanners; Positron Emission Tomography (PET) Scanners; Electroencephalography (EEG) Devices; Functional MRI (fMRI) Systems; Single Photon Emission Computed Tomography (SPECT) Scanners2) By Accessories: Contrast Agents; MRI Coils; EEG Electrodes; Image Processing Software; Patient Monitoring Systems
3) By Usability: Portable Brain Imaging Devices; Stationary Brain Imaging Systems; Point-Of-Care Brain Imaging Solutions; Research-Oriented Brain Imaging Equipment
Companies Mentioned: Hitachi Ltd; Siemens AG; Toshiba Corporation; FUJIFILM Corporation; Koninklijke Philips N.V; GE HealthCare Technologies Inc.; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; Shimadzu Corporation; Canon Medical Systems Corporation; Neusoft Corporation; Agfa-Gevaert N.V.; Carestream Health; Brainlab AG; Esaote SpA; NeuroLogica Corp.; Swissray International Inc.; Xoran Technologies LLC.; Allengers Medical Systems Ltd.; Konica Minolta Healthcare Americas Inc.; Hi-Tech Medical Imaging
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Brain Imaging Modalities market report include:- Hitachi Ltd
- Siemens AG
- Toshiba Corporation
- FUJIFILM Corporation
- Koninklijke Philips N.V
- GE HealthCare Technologies Inc.
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- Shimadzu Corporation
- Canon Medical Systems Corporation
- Neusoft Corporation
- Agfa-Gevaert N.V.
- Carestream Health
- Brainlab AG
- Esaote SpA
- NeuroLogica Corp.
- Swissray International Inc.
- Xoran Technologies LLC.
- Allengers Medical Systems Ltd.
- Konica Minolta Healthcare Americas Inc.
- Hi-Tech Medical Imaging
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 14.76 Billion |
| Forecasted Market Value ( USD | $ 18.55 Billion |
| Compound Annual Growth Rate | 5.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
